RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson to...
Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today announced the...
Dr. Rousseau to lead clinical development as Pheast advances PHST001, a novel anti-CD24 macrophage checkpoint inhibitor, into clinical trials Pheast Therapeutics, a private biotechnology company...
Gravie, one of the nation’s fastest growing health benefits innovators, has named Steve Wolin as the company’s new chief executive. Wolin succeeds Gravie Co-founder and CEO Abir Sen,...
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services...
Ingenovis Health today announced the promotion of Jan Ross to Chief Information Officer, effective immediately. Ross joined the company in March 2023 as Senior Vice...
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced the appointment of Joshua Bleharski, Ph.D....
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, with the late-stage asset tecarfarin, a new Vitamin...
Viventium, the leading SaaS-based human capital management platform serving the healthcare industry, announces the addition of Open Shift Management to Viventium Scheduling, Viventium’s proprietary and innovative...
New AOC CEO focused on strategy, specialization and serving the broader Athens community with accessible, world-class care Athens Orthopedic Clinic (AOC), a cornerstone of specialized...